Replies to post #175440 on Cytodyn Inc (CYDY)

[theswordman]

so from your "wording" that is this trial:

https://clinicaltrials.gov/ct2/show/NCT02574455?term=Sacituzumab+Govitecan&cond=breast+cancer&draw=2&rank=5

Open-Label, Randomized, Phase III Trial of Sacituzumab Govitecan Versus Treatment of Physician Choice in Patients With Metastatic Triple-Negative Breast Cancer Who Received at Least Two Prior Treatments

so NOT a combo trial--it was SG versus TPC